W
Walter Cunto
Researcher at IBM
Publications - 24
Citations - 1127
Walter Cunto is an academic researcher from IBM. The author has contributed to research in topics: Binary search tree & Rotavirus. The author has an hindex of 12, co-authored 24 publications receiving 1115 citations. Previous affiliations of Walter Cunto include Simón Bolívar University.
Papers
More filters
Journal ArticleDOI
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela
Irene Pérez-Schael,María J. Guntiñas,Mireya Perez,Vito Pagone,Ana M. Rojas,Rosabel González,Walter Cunto,Yasutaka Hoshino,Albert Z. Kapikian +8 more
TL;DR: The vaccine was safe, although 15 percent of the vaccinated infants had febrile episodes (rectal temperature, >38.1°C) during the six days after the first dose, as compared with 7 percent of all the controls.
Book ChapterDOI
Proximity Matching Using Fixed-Queries Trees
TL;DR: This work presents a new data structure, called the fixed-queries tree, for the problem of finding all elements of a fixed set that are close to a query element under some distance function.
Journal ArticleDOI
Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in venezuelan infants
Jorge Flores,Marino Gonzalez,Mireya Perez,Walter Cunto,Irene Pérez-Schael,D. García,Naimeh Daoud,R M Chanock,A Z Kapikian +8 more
TL;DR: For the entire study group vaccine efficacy was 100% against the most severe rotavirus diarrhoeal episodes.
Journal ArticleDOI
Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine.
Irene Pérez-Schael,D. García,Marino Gonzalez,Rosabel González,Naimeh Daoud,Mireya Perez,Walter Cunto,Albert Z. Kapikian,Jorge Flores +8 more
TL;DR: Serotypic analysis of the rotaviruses detected suggests that the resistance induced by the vaccine was type specific since significant protection was only evident against serotype 3 rotavirus, and was notably high in the 1–4 month age group.
Journal ArticleDOI
Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
Jorge Flores,A Z Kapikian,Irene Pérez-Schael,Mario Blanco,Laura White,D. García,M. Vilar,Rosabel González,C. Urbina,J. Boher,M. Mendez,Walter Cunto +11 more
TL;DR: 90 Venezuelan infants aged 10-20 weeks were randomly allocated to four groups which received one of the following: the M37 vaccine, quadrivalent rotavirus vaccine, balanced quadrivalents, balanced-quadrivalent vaccine, or placebo.